184 related articles for article (PubMed ID: 1423504)
1. A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease.
Shen Z; Larsson LT; Malmfors G; Absood A; Håkanson R; Sundler F
Cell Tissue Res; 1992 Aug; 269(2):369-74. PubMed ID: 1423504
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut.
Sundler F; Ekblad E; Absood A; Håkanson R; Köves K; Arimura A
Neuroscience; 1992; 46(2):439-54. PubMed ID: 1542417
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation.
Hannibal J; Ekblad E; Mulder H; Sundler F; Fahrenkrug J
Cell Tissue Res; 1998 Jan; 291(1):65-79. PubMed ID: 9394044
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical investigation of vasoactive intestinal polypeptide in the colon of patients with Hirschsprung's disease.
Tsuto T; Okamura H; Fukui K; Obata HL; Terubayashi H; Iwai N; Majima S; Yanaihara N; Ibata Y
Neurosci Lett; 1982 Dec; 34(1):57-62. PubMed ID: 6761608
[TBL] [Abstract][Full Text] [Related]
5. Changes in vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide and neuropeptide Y-ergic structures of the enteric nervous system in the carcinoma of the human large intestine.
Godlewski J; Łakomy IM
Folia Histochem Cytobiol; 2010 Jan; 48(2):208-16. PubMed ID: 20675276
[TBL] [Abstract][Full Text] [Related]
6. Hirschsprung's disease--immunohistochemical findings.
Larsson LT
Histol Histopathol; 1994 Jul; 9(3):615-29. PubMed ID: 7981507
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation.
Kirchgessner AL; Liu MT
Anat Rec; 2001 Jan; 262(1):91-100. PubMed ID: 11146432
[TBL] [Abstract][Full Text] [Related]
8. NPY hyperinnervation in Hirschsprung's disease: both adrenergic and nonadrenergic fibers contribute.
Larsson LT; Malmfors G; Ekblad E; Ekman R; Sundler F
J Pediatr Surg; 1991 Oct; 26(10):1207-14. PubMed ID: 1685748
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A and B in neuronal elements in Hirschsprung's disease: an immunocytochemical and radioimmunoassay study.
Shen Z; Larsson LT; Malmfors G; Oberg K; Eriksson B; Sundler F
J Pediatr Surg; 1994 Oct; 29(10):1293-301. PubMed ID: 7807311
[TBL] [Abstract][Full Text] [Related]
10. Distribution of PACAP (pituitary adenylate cyclase-activating polypeptide)-like and helospectin-like peptides in the teleost gut.
Olsson C; Holmgren S
Cell Tissue Res; 1994 Sep; 277(3):539-47. PubMed ID: 7954690
[TBL] [Abstract][Full Text] [Related]
11. CART-peptide immunoreactivity in enteric nerves in patients with Hirschsprung's disease.
Gunnarsdóttir A; Wierup N; Larsson LT; Kuhar MJ; Ekblad E
Eur J Pediatr Surg; 2007 Jun; 17(3):184-9. PubMed ID: 17638157
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats.
Vereczki V; Köves K; Tóth ZE; Baba A; Hashimoto H; Fógel K; Arimura A; Kausz M
Endocrine; 2003 Dec; 22(3):225-37. PubMed ID: 14709795
[TBL] [Abstract][Full Text] [Related]
13. Is the reduction of VIP the clue to the pathophysiology of Hirschsprung's disease?
Larsson LT; Sundler F
Z Kinderchir; 1990 Jun; 45(3):164-6. PubMed ID: 2375187
[TBL] [Abstract][Full Text] [Related]
14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin.
Fahrenkrug J; Hannibal J
Neuroscience; 1996 Aug; 73(4):1049-60. PubMed ID: 8809823
[TBL] [Abstract][Full Text] [Related]
16. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.
Köves K; Arimura A; Görcs TG; Somogyvári-Vigh A
Neuroendocrinology; 1991 Aug; 54(2):159-69. PubMed ID: 1766552
[TBL] [Abstract][Full Text] [Related]
17. Innervation of the rat pineal gland by pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive nerve fibres.
Møller M; Fahrenkrug J; Hannibal J
Cell Tissue Res; 1999 May; 296(2):247-57. PubMed ID: 10382269
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y, calcitonin gene-related peptide, and galanin in Hirschsprung's disease: an immunocytochemical study.
Larsson LT; Malmfors G; Sundler F
J Pediatr Surg; 1988 Apr; 23(4):342-5. PubMed ID: 2455034
[TBL] [Abstract][Full Text] [Related]
19. Segmental distribution of colonic neuropeptides in Hirschsprung's disease.
Johanson JF; Carney JA; Go VL; Koch TR
Regul Pept; 1991 Oct; 36(1):59-69. PubMed ID: 1724567
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
